Renal Cell Carcinoma: Diffusion-weighted MR Imaging for Subtype Differentiation at 3.0 T
Abstract
Clear cell and non–clear cell renal cell carcinomas possess different diffusion characteristics that can be distinguished with high sensitivity and specificity when b values of 0 and 800 sec/mm2 are used to calculate apparent diffusion coefficients.
Purpose
To assess the usefulness of apparent diffusion coefficients (ADCs) for characterizing renal cell carcinoma (RCC) subtypes at 3.0 T.
Materials and Methods
The Institutional Review Board approved this retrospective study, and informed consent was waived. Eighty-three patients underwent diffusion-weighted (DW) magnetic resonance (MR) imaging of 85 renal masses. In each patient, precontrast single-shot spin-echo echo-planar DW imaging was performed with b values of 0 and 500 and 0 and 800 sec/mm2 by using a 3.0-T MR imaging system. Differences in ADCs between the RCC lesions and uninvolved renal parenchyma were tested by using a paired-samples t test. One-way analysis of variance was used to compare ADCs of the various RCC subtypes. Receiver operating characteristic (ROC) curve analysis was used to test the ability of ADCs in differentiating clear cell from non–clear cell RCCs.
Results
Pathologic diagnoses of the 85 tumors (median diameter, 4.4 cm) in the 83 patients (54 men, 29 women; age range, 23–75 years; mean age, 49.4 years) were clear cell RCC for 49 tumors, papillary RCC for 22 tumors, and chromophobic RCC for 14 tumors. With b values of 0 and 500 sec/mm2, clear cell RCCs showed a significantly higher mean ADC (1.849 × 10−3 mm2/sec) than papillary (1.087 × 10−3 mm2/sec) and chromophobic (1.307 × 10−3 mm2/sec) RCCs (P < .001); however, the difference between papillary and chromophobic RCCs was not significant (P = .068). With b values of 0 and 800 sec/mm2, clear cell RCC showed the largest mean ADC (1.698 × 10−3 mm2/sec) of the three subtypes, and the difference between each pair of subtypes was significant (P < .001). ADCs obtained with b values of 0 and 800 sec/mm2 were more effective for distinguishing clear cell from non–clear cell RCC (area under the ROC curve, 0.973): A threshold value of 1.281 × 10−3 mm2/sec permitted distinction with high sensitivity (95.9%) and specificity (94.4%).
Conclusion
DW imaging with b values of 0 and 800 sec/mm2 allows sensitive and specific differentiation of clear cell, papillary, and chromophobic RCCs, suggesting that DW imaging may be useful in the preoperative characterization of RCC.
© RSNA, 2010
References
- 1 Eble JNSauter GEpstein JISesterhenn IA, eds. Pathology and genetics: tumours of the urinary system and male genital organs. Lyon, France: IARC, 2004; 65. Google Scholar
- 2 . The pathology of renal epithelial neoplasms. Semin Oncol 2006;33(5):534–543. Crossref, Medline, Google Scholar
- 3 . Current trends in the molecular classification of renal neoplasms. ScientificWorldJournal 2006;6:2505–2518. Crossref, Medline, Google Scholar
- 4 . Advances in molecular classification of renal neoplasms. Histol Histopathol 2006;21(3):325–339. Medline, Google Scholar
- 5 . Prognostic value of histologic subtypes in renal cell carcinoma: a multicenter experience. J Clin Oncol 2005;23(12):2763–2771. Crossref, Medline, Google Scholar
- 6 . Comparisons of outcome and prognostic features among histologic subtypes of renal cell carcinoma. Am J Surg Pathol 2003;27(5):612–624. Crossref, Medline, Google Scholar
- 7 . Effect of papillary and chromophobe cell type on disease-free survival after nephrectomy for renal cell carcinoma. Ann Surg Oncol 2004;11(1):71–77. Crossref, Medline, Google Scholar
- 8 . Sorafenib in advanced clear-cell renal-cell carcinoma. N Engl J Med 2007;356(2):125–134. [Published correction appears in N Engl J Med 2007;357(2):203.] Crossref, Medline, Google Scholar
- 9 . Sunitinib versus interferon alfa in metastatic renal-cell carcinoma. N Engl J Med 2007;356(2):115–124. Crossref, Medline, Google Scholar
- 10 . Recent advances in the systemic treatment of metastatic papillary renal cancer. Expert Rev Anticancer Ther 2009;9(3):373–379. Crossref, Medline, Google Scholar
- 11 . Metastatic non-clear cell renal cell carcinoma: current therapeutic options. BJU Int 2008;101(11):1343–1345. Crossref, Medline, Google Scholar
- 12 . Percutaneous kidney biopsy, analysis of 26 years: complication rate and risk factors; comment [in Spanish]. Rev Invest Clin 2000;52(2):125–131. Medline, Google Scholar
- 13 . Percutaneous core biopsy for renal masses: indications, accuracy and results. J Urol 2007;178(4 pt 1):1184–1188; discussion 1188. Crossref, Medline, Google Scholar
- 14 . Diffusion-weighted MR imaging of the brain. Radiology 2000;217(2):331–345. Link, Google Scholar
- 15 . Echo planar imaging of the abdomen. Top Magn Reson Imaging 1995;7(2):112–119. Medline, Google Scholar
- 16 . Lung carcinoma: diffusion-weighted MR imaging—preliminary evaluation with apparent diffusion coefficient. Radiology 2007;243(2):570–577. Link, Google Scholar
- 17 . Diffusion-weighted imaging in the differential diagnosis of simple and hydatid cysts of the liver. AJR Am J Roentgenol 2007;189(5):1031–1036. Crossref, Medline, Google Scholar
- 18 . Quantitative analysis of diffusion-weighted magnetic resonance imaging of the pancreas: usefulness in characterizing solid pancreatic masses. J Magn Reson Imaging 2008;28(4):928–936. Crossref, Medline, Google Scholar
- 19 . Diffusion-weighted MRI in evaluating liver fibrosis: a feasibility study in cirrhotic patients. Radiol Med (Torino) 2007;112(3):394–408. Crossref, Medline, Google Scholar
- 20 . Relationship between the renal apparent diffusion coefficient and glomerular filtration rate: preliminary experience. J Magn Reson Imaging 2007;26(3):678–681. Crossref, Medline, Google Scholar
- 21 . Diffusion-weighted magnetic resonance imaging in the evaluation of renal function: a preliminary study. Radiol Med (Torino) 2007;112(8):1201–1210. Crossref, Medline, Google Scholar
- 22 . Diffusion-weighted MRI in the evaluation of renal lesions: preliminary results. Br J Radiol 2004;77(922):851–857. Crossref, Medline, Google Scholar
- 23 . Renal masses: characterization with diffusion-weighted MR imaging—a preliminary experience. Radiology 2008;247(2):458–464. Link, Google Scholar
- 24 . Correlation of diffusion-weighted MR imaging with cellularity of renal tumours. Anticancer Res 2004;24(6):4175–4179. Medline, Google Scholar
- 25 . Variability of renal apparent diffusion coefficients: limitations of the monoexponential model for diffusion quantification. Radiology 2010;254(3):783–792. Link, Google Scholar
- 26 . Diffusion-weighted single-shot echoplanar MR imaging for liver disease. AJR Am J Roentgenol 1999;173(2):393–398. Crossref, Medline, Google Scholar
- 27 . Renal lesions: characterization with diffusion-weighted imaging versus contrast-enhanced MR imaging. Radiology 2009;251(2):398–407. Link, Google Scholar
- 28 . The role of the ADC value in the characterisation of renal carcinoma by diffusion-weighted MRI. Br J Radiol 2010;83(988):336–343. Crossref, Medline, Google Scholar
- 29 . Mechanism of detection of acute cerebral ischemia in rats by diffusion-weighted magnetic resonance microscopy. Stroke 1992;23(5):746–754. Crossref, Medline, Google Scholar
- 30 . Echo-planar MR imaging. Radiology 1994;192(3):600–612. Link, Google Scholar
- 31 . Renal cell carcinoma: dynamic contrast-enhanced MR imaging for differentiation of tumor subtypes—correlation with pathologic findings. Radiology 2009;250(3):793–802. Link, Google Scholar
- 32 . T1 hyperintense renal lesions: characterization with diffusion-weighted MR imaging versus contrast-enhanced MR imaging. Radiology 2009;251(3):796–807. Link, Google Scholar
- 33 . Abdominal applications of 3.0-T MR imaging: comparative review versus a 1.5-T system. RadioGraphics 2008;28(4):e30. Link, Google Scholar
- 34 . ADC measurement of abdominal organs and lesions using parallel imaging technique. AJR Am J Roentgenol 2006;187(6):1521–1530. Crossref, Medline, Google Scholar
- 35 . Comparison of 3.0-and 1.5-tesla diffusion-weighted imaging in the visibility of breast cancer. Radiat Med 2008;26(1):15–20. Crossref, Medline, Google Scholar
- 36 . Field strength and diffusion encoding technique affect the apparent diffusion coefficient measurements in diffusion-weighted imaging of the abdomen. Invest Radiol 2010;45(2):104–108. Crossref, Medline, Google Scholar
- 37 . Quantitative diffusion tensor MR imaging of the brain: field strength related variance of apparent diffusion coefficient (ADC) and fractional anisotropy (FA) scalars. Eur Radiol 2006;16(8):1651–1658. Crossref, Medline, Google Scholar
Article History
Received December 28, 2009; revision requested February 19, 2010; revision received March 18; accepted April 23; final version accepted May 10.Published online: Oct 2010
Published in print: Oct 2010